Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Co-Diagnostics Sales Plunge 93 Percent
Co-Diagnostics Sales Plunge 93 Percent

Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than

Daré Bioscience Posts Narrower Q2 Loss
Daré Bioscience Posts Narrower Q2 Loss

Daré Bioscience (NASDAQ:DARE), a women’s health-focused biopharmaceutical company developing new therapies and devices, announced its second quarter 2025 results on August 14, 2025. The headline

Why Dillard's Rallied Today
Why Dillard's Rallied Today

Shares of department store company Dillard's (NYSE: DDS) rallied on Thursday, up 5.4% as of 2 p.m. ET.

Dillard's reported second-quarter earnings that, while certainly not eye-opening from a growth

Advance Auto Parts Returns to Profit in Q2
Advance Auto Parts Returns to Profit in Q2

Advance Auto Parts(NYSE:AAP) reported second-quarter 2025 results on Aug. 14, 2025, with GAAP net sales of $2 billion, down 8% year-over-year, and adjusted earnings per share (EPS) of $0.69. The

Amcor Sees 12% EPS Growth Ahead
Amcor Sees 12% EPS Growth Ahead

Amcor(NYSE:AMCR) reported fiscal fourth quarter 2025 results on August 14, 2025, highlighting the completed Berry Global acquisition, new synergy targets, and a comprehensive portfolio review

Why Nice Stock Sank Today
Why Nice Stock Sank Today

Shares of leading enterprise software provider Nice (NASDAQ: NICE) had dropped 7% as of 11 a.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Nice reported

Applied Industrial Hits Record Sales
Applied Industrial Hits Record Sales

Applied Industrial Technologies(NYSE:AIT) reported its fiscal fourth quarter ended June 30, 2025, earnings on August 14, 2025, delivering record full-year sales, EBITDA, and EPS for the fiscal year

1 Magnificent High-Yield Stock Down 15% to Buy and Hold Forever
1 Magnificent High-Yield Stock Down 15% to Buy and Hold Forever

An inflation spike coming out of the coronavirus pandemic helped to boost the profits of energy companies. But after hitting a peak, oil and natural gas prices have come back down. That has taken

Ideal Power Misses Q2 Revenue by 93%
Ideal Power Misses Q2 Revenue by 93%

Ideal Power (NASDAQ:IPWR), a developer of efficient power semiconductor devices, published its second quarter 2025 results on August 14, 2025. The most notable news from the earnings release was a

Applied Industrial Q4 Earnings Jump 6%
Applied Industrial Q4 Earnings Jump 6%

Applied Industrial Technologies (NYSE:AIT), a major distributor of industrial motion, fluid power, and automation components, reported its fiscal fourth quarter 2025 results on August 14, 2025. The

Air Industries Revenue Drops 6.6% in Q2
Air Industries Revenue Drops 6.6% in Q2

Air Industries Group (NYSEMKT:AIRI), a supplier of precision components and assemblies for the defense and aerospace industries, released its Q2 2025 earnings report on August 14, 2025. The company

Contango Ore Posts Record Profit in Q2
Contango Ore Posts Record Profit in Q2

Contango Ore (NYSEMKT:CTGO), an Alaska-focused gold exploration and production company, posted a record quarter in its earnings release on August 13, 2025. The company reported GAAP earnings per

MSC Income Fund Posts 22% Gain
MSC Income Fund Posts 22% Gain

MSC Income Fund (NYSE:MSIF), a business development company specializing in private loans and lower middle market investments, reported its second-quarter fiscal 2025 results on August 13, 2025. The

Cocrystal Pharma Narrows Loss in Q2
Cocrystal Pharma Narrows Loss in Q2

Cocrystal Pharma (NASDAQ:COCP), a clinical-stage biotech focusing on antiviral drug development, released its second quarter 2025 earnings on August 14, 2025. The company’s report highlighted a

CoreCard Revenue Jumps 28 Percent in Q2
CoreCard Revenue Jumps 28 Percent in Q2

CoreCard (NYSE:CCRD), a provider of financial technology software and services, delivered its second quarter 2025 earnings on August 14, 2025. The main highlight was a surge in both revenue and

Galectin Beats Q2 Loss Estimates
Galectin Beats Q2 Loss Estimates

Galectin Therapeutics (NASDAQ:GALT), a clinical-stage biotech firm focused on liver fibrosis and cancer, reported its second quarter 2025 results on August 14, 2025. The most significant news was a

Qxo Posts 1,906 Million Revenue in Q2
Qxo Posts 1,906 Million Revenue in Q2

Qxo (NYSE:QXO), a rapidly transforming distributor of building products, released its second quarter earnings for fiscal 2025 on August 14, 2025. The most notable news was that it recorded Adjusted

FitLife Brands Reports 5 Percent Q2 Drop
FitLife Brands Reports 5 Percent Q2 Drop

FitLife Brands (NASDAQ:FTLF), a nutritional supplements company with products spanning sports nutrition, weight management, and general wellness, released its financial results for the second

Atai Life Sciences Revenue Jumps 163%
Atai Life Sciences Revenue Jumps 163%

Atai Life Sciences (NASDAQ:ATAI), a biotechnology company developing novel treatments for mental health conditions, reported its results for the second quarter of fiscal 2025 on August 14, 2025. The

Werewolf Reports No Revenue in Fiscal Q2
Werewolf Reports No Revenue in Fiscal Q2

Werewolf Therapeutics (NASDAQ:HOWL), an early-stage biotechnology company dedicated to innovative cancer immunotherapies, reported its second quarter 2025 results on August 14, 2025. The main story

Bk Technologies EPS Jumps 136 Percent
Bk Technologies EPS Jumps 136 Percent

Bk Technologies (NYSEMKT:BKTI), a public safety radio and communications equipment provider, released its second quarter fiscal 2025 results on August 14, 2025. The company posted a major earnings

Protalix Revenue Jumps 16 Percent in Q2
Protalix Revenue Jumps 16 Percent in Q2

Protalix BioTherapeutics (NYSEMKT:PLX), a biopharmaceutical company specializing in plant cell-based protein production, announced its second quarter results on August 14, 2025. Revenues from

Deere Beats Fiscal Q3 EPS as Sales Fall
Deere Beats Fiscal Q3 EPS as Sales Fall

Deere & Company (NYSE:DE), a leading manufacturer of agricultural, construction, and forestry equipment, reported results for fiscal Q3 2025 (ended July 27, 2025) on August 14, 2025. The company

BCG Reports Earnings
BCG Reports Earnings

Binah Capital Group (NASDAQ:BCG), a wealth management and brokerage platform serving financial advisors and their clients, released its second quarter 2025 financial results on August 13, 2025. In

3 Reasons to Buy Chevron Stock Like There's No Tomorrow
3 Reasons to Buy Chevron Stock Like There's No Tomorrow

Chevron (NYSE: CVX) is at a pivotal moment. The oil giant is on the cusp of a major free-cash-flow surge. It has also significantly enhanced its long-term growth trajectory through a series of